Glycorex Transplantation AB Stock
Equities
GTAB B
SE0000524530
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.998 SEK | +3.31% | +12.39% | -24.68% |
Sales 2021 | 29.01M 2.76M | Sales 2022 | 37.39M 3.56M | Capitalization | 303M 28.82M |
---|---|---|---|---|---|
Net income 2021 | -12M -1.14M | Net income 2022 | -8M -761K | EV / Sales 2021 | 22.5 x |
Net cash position 2021 | 33.08M 3.15M | Net cash position 2022 | 23.52M 2.24M | EV / Sales 2022 | 7.47 x |
P/E ratio 2021 |
-56.1
x | P/E ratio 2022 |
-35.3
x | Employees | 23 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 95.58% |
1 day | +3.31% | ||
1 week | +12.39% | ||
1 month | -0.20% | ||
3 months | -0.20% | ||
6 months | -35.61% | ||
Current year | -24.68% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Laven
CEO | Chief Executive Officer | 51 | 21-12-31 |
Founder | 71 | 95-12-31 | |
Sales & Marketing | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 95-12-31 | |
Nils Siegbahn
CHM | Chairman | 71 | 99-12-31 |
Clas Runnberg
BRD | Director/Board Member | 72 | 22-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.998 | +3.31% | 22,428 |
24-05-30 | 0.966 | +9.52% | 65,335 |
24-05-29 | 0.882 | +2.56% | 20,210 |
24-05-28 | 0.86 | -3.59% | 20,092 |
24-05-27 | 0.892 | +0.45% | 2,845 |
End-of-day quote NORDIC GROWTH MARKET, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-24.68% | 7M | |
+6.84% | 26.97B | |
-40.60% | 2.67B | |
-19.95% | 2.4B | |
+16.30% | 2.28B | |
+7.28% | 2.24B | |
-13.56% | 1.82B | |
+16.67% | 1.79B | |
+18.92% | 1.26B | |
-2.99% | 1.21B |
- Stock Market
- Equities
- GTAB B Stock